Actively Recruiting
Digital-supported Orofacial Myofunctional Therapy in OSA
Led by Hong Kong Metropolitan University · Updated on 2026-03-13
60
Participants Needed
1
Research Sites
68 weeks
Total Duration
On this page
Sponsors
H
Hong Kong Metropolitan University
Lead Sponsor
Q
Queen Mary Hospital, Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity. Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30). Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.
CONDITIONS
Official Title
Digital-supported Orofacial Myofunctional Therapy in OSA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and above
- Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as Apnoea-Hypopnea Index of 5-30 events per hour
- Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments
- Body Mass Index less than 30 kg/m2
You will not qualify if you...
- Presence of obstructive nasal disease or significant nasal obstruction
- Unstable mental health issues
- History of stroke
- Unstable chronic respiratory, cardiac, neurological conditions
- Inability to provide informed consent
- Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen Mary Hopsital
Hong Kong, Hong Kong, Hong Kong
Actively Recruiting
Research Team
A
Agnes YK Lai, PhD
CONTACT
G
George OC Cheung, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here